1. South Korea Stocks

  2. •

    Consumer Cyclical

  3. •

    Apparel - Footwear & Accessories
INBIOGEN Co., Ltd.

INBIOGEN Co., Ltd.

101140.KS
INBIOGEN Co., Ltd.KR flagKorea Exchange
5,730.00
KRW
-130.00
- -
57.21BMarket Cap
INBIOGEN Co., Ltd.
101140.KS
(Korea Exchange)

Recent

price

5,730.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
7,193.56
12,560.5
18,111.54
14,186.05
20,600.79
9,572.43
11,464.02
6,428.37
6,638.47
6,120.17
4,941.4
3,903.93
76,530.85
733.33
705.31
630.27
545.19
Revenue per Share
-6,820
835.35
-2,438
-2,458
-2,824
-6,140
-2,240
-1,100
1,460
8,200
-21,800
35,060
-860,961.66
1,333
1,615
-142
-1,815.57
Basic EPS, GAAP
86.31
-5,877.06
646.16
-2,209.05
-1,261.39
-11,981.92
342.32
-387.37
-1,490.56
-2,651.63
-4,354.38
-3,527.71
-86,933.44
-162.35
-11.76
-560.18
-435.6
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-8,440.88
-26,763.34
-57,615.81
-59,937.07
-59,727.77
-39,402.05
-38,455.83
-34,639.64
-29,646.23
-9,576.01
-26,093.25
15,304.46
-237,879.6
1,052.53
2,513.49
2,349.9
881.25
Book Value per Share
178.77
6,053.16
8,019.84
6,509.66
7,211.22
8,417.18
5,708.66
10,286.41
20,488.39
41,158.55
37,416.96
66,138.15
781,301.44
16,736.77
15,991.93
15,779.17
14,307.61
Tangible Book Value per Share
2
1
1
1
1
1
1
1
1
2
2
3
- -
9
10
10
10
Basic Weighted Avg Shares
14,649
11,947
10,168
7,966
11,762
8,865
11,545
7,077
7,566
9,795
10,218
10,481
10,420
6,241
7,041
6,297
5,444
Sales/Revenue/Turnover
-13.82
8.46
-11.94
-16.12
-10.85
-55.81
-18.47
-21.64
18.07
-21.71
-52.95
-73.33
-57.28
-98.38
-86.45
-68.81
-73.31
Operating Margin (%)
60
58
58
46
40
52
52
49
35
255
443
1,117
1,438
1,224
1,057
363
242
Depreciation Expense
-13,888
795
-1,369
-1,380
-1,612
-5,686
-2,256
-1,211
1,664
13,124
-45,078
94,125
-117,218
11,344
16,122
-1,419
-18,128
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
15.25
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-94.81
6.65
-13.46
-17.33
-13.71
-64.14
-19.54
-17.11
21.99
133.98
-441.17
898.07
-1,124.99
181.77
228.98
-22.53
-333.01
Profit Margin (%)
1,574
5,956
4,834
6,462
4,421
10,901
6,368
12,001
23,320
8,382
67,715
-45,873
-19,628
9,218
7,164
3,460
2,807
Working Capital
1,030
- -
- -
2,596
- -
2,811
318
318
- -
118
246
1,064
553
330
668
426
363
LT Debt
437
5,805
4,526
3,670
4,124
7,800
5,751
11,324
23,352
65,996
77,906
178,023
106,884
143,083
159,837
157,644
142,975
Total Equity
- -
26.38
- -
- -
- -
- -
- -
- -
- -
-4.38
- -
-4.8
- -
-4.9
-4.01
- -
-3.42
Return on Invested Capital (%)
- -
-5.11
- -
- -
- -
- -
- -
- -
- -
-88.63
- -
3,664.32
- -
-110.21
91.02
- -
153.92
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
94.7
-5.84
-100.93
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
238
741
3,746
LT Borrowings
- -
- -
- -
LT Finance Leases
488
426
363
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
10
10
10
Market Capitalization
120,907
104,819
96,554

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
5,575
5,321
7,744
Cash, Cash Equivalents & STI
1,009
902
3,533
Accounts Receivable, Net
507
486
501
Inventories
31
30
- -
Total Current Liabilities
1,882
1,862
4,937
Payables & Accruals
- -
- -
- -
ST Debt
238
741
3,746
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
51.03%
26.55%
-1.37%
Free Cash Flow
475.05%
903.4%
4,666.66%
Net Income, GAAP
-80.86%
-141.94%
-108.8%
Sales/Revenue/Turnover
-0.36%
-7.17%
-10.57%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,369
1,424
2,081
2,167
7,041
2025
1,639
1,850
2,147
661
6,297
2026
786
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
861
-435
-443
- -
1,615
2025
203
112.53
818.34
- -
-142
2026
-1,470
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Vulcabras S.A. (VULC3.SA)
Delta Plus Group (DLTA.PA)
Palemo Holdings Co.,Ltd. (2778.T)
Bravada International Ltd. (BRAV)
Hermes International Societe en commandite par actions Unsponsored ADR (HESAY)
NIKE, Inc. (NKE.BA)
Business
INBIOGEN Co., Ltd. (101140.KS) manufactures and distributes footwear products; operates unmanned kiosks for payments; distributes wood pellets and sawdust; and engages in food and beverage businesses, including online and offline education for FinTech, platform, and blockchain human resources development. The company operates through four segments—kiosk business providing unmanned payment machines for restaurants, karaoke rooms, and PC rooms; footwear business selling children's and adult shoes such as hiking, skate, and running shoes; wood pellet business; and other businesses—primarily targeting the South Korean market. Founded in 1949 and headquartered in Seoul at Initial Tower, 6th and 7th floors, Gangnam-gu, INBIOGEN focuses on wholesale distribution of computers, peripheral equipment, and software alongside its core operations. Previously known as BTOne Co., Ltd., the company underwent a significant name change to INBIOGEN Co., Ltd., reflecting a strategic shift in its business identity and operations. In November 2022, INBIOGEN received KRW 12 billion in funding from Bucket Studio Co., Ltd., supporting its diversified portfolio expansion. These developments underscore recent financial strengthening and adaptation across its kiosk, footwear, and related segments amid ongoing market dynamics in South Korea.